Viking Therapeutics, Inc. Common Stock (NASDAQ: VKTX) last traded at $26.65, down 5.96% on the session. The quote above updates while this page is open; the figures below are drawn from Viking Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Viking Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker VKTX. Its market capitalisation is $3.11 billion.
Valuation measures for Viking Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.11B |
|---|---|
| Enterprise value | $3.10B |
| Price / book | 7.61 |
| Beta | 1.11 |
Trailing-twelve-month figures tagged in Viking Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$534.80M |
|---|
| EPS (TTM) | -$4.67 |
|---|
| Return on equity | -130.98% |
|---|
| Cash | $125.75M |
|---|
Range and volume for VKTX over the past 52 weeks.
| 52-week high | $43.15 |
|---|---|
| 52-week low | $25.77 |
| Volume | 5.69M |
| Average volume | 4.20M |
| Previous close | $28.34 |
Invest a chosen dollar amount in Viking Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell VKTX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.